TY - JOUR
T1 - Combined effects of space flight factors and radiation on humans
AU - Todd, Paul
AU - Pecaut, Michael J.
AU - Fleshner, Monika
N1 - Funding Information:
Portions of the research reported here were supported by National Cancer Institute Grant R01 CA35370 from the U.S. Public Health Service, NASA Contracts NAS9-17431, NAGW-694 and NAS9-15583 from Johnson Space Center, NASA Grant NAGW-2356 to the NASA Specialized Center on Research and Training (NSCORT) in Space Environmental Health and NASA Grant NAGW-1197 to BioServe Space Technologies Center for Space Commercialization.
PY - 1999/12/6
Y1 - 1999/12/6
N2 - The probability that a dose of ionizing radiation kills a cell is about 10,000 times the probability that the cell will be transformed to malignancy. On the other hand, the number of cells killed required to significantly impact health is about 10,000 times the number that must be transformed to cause a late malignancy. If these two risks, cell killing and malignant transformation, are about equal, then the risk that occurs during a mission is more significant than the risk that occurs after a mission. The latent period for acute irradiation effects (cell killing) is about 2-4 weeks; the latent period for malignancy is 10-20 years. If these statements are approximately true, then the impact of cell killing on health in the low-gravity environment of space flight should be examined to establish an estimate of risk. The objective of this study is to synthesize data and conclusions from three areas of space biology and environmental health to arrive at rational risk assessment for radiations received by spacecraft crews: (1) the increased physiological demands of the space flight environment; (2) the effects of the space flight environment on physiological systems; and (3) the effects of radiation on physiological systems. One physiological system has been chosen: the immune response and its components, consisting of myeloid and lymphoid proliferative cell compartments. Best-case and worst-case scenarios are considered. In the worst case, a doubling of immune-function demand, accompanied by a halving of immune capacity, would reduce the endangering dose to a crew member to around 1 Gy. Copyright (C) 1999.
AB - The probability that a dose of ionizing radiation kills a cell is about 10,000 times the probability that the cell will be transformed to malignancy. On the other hand, the number of cells killed required to significantly impact health is about 10,000 times the number that must be transformed to cause a late malignancy. If these two risks, cell killing and malignant transformation, are about equal, then the risk that occurs during a mission is more significant than the risk that occurs after a mission. The latent period for acute irradiation effects (cell killing) is about 2-4 weeks; the latent period for malignancy is 10-20 years. If these statements are approximately true, then the impact of cell killing on health in the low-gravity environment of space flight should be examined to establish an estimate of risk. The objective of this study is to synthesize data and conclusions from three areas of space biology and environmental health to arrive at rational risk assessment for radiations received by spacecraft crews: (1) the increased physiological demands of the space flight environment; (2) the effects of the space flight environment on physiological systems; and (3) the effects of radiation on physiological systems. One physiological system has been chosen: the immune response and its components, consisting of myeloid and lymphoid proliferative cell compartments. Best-case and worst-case scenarios are considered. In the worst case, a doubling of immune-function demand, accompanied by a halving of immune capacity, would reduce the endangering dose to a crew member to around 1 Gy. Copyright (C) 1999.
KW - Astronauts
KW - Combined risk
KW - Immune system
KW - Microgravity
KW - Space environmental health
KW - Space radiation
UR - http://www.scopus.com/inward/record.url?scp=0033385866&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033385866&partnerID=8YFLogxK
U2 - 10.1016/S0027-5107(99)00132-3
DO - 10.1016/S0027-5107(99)00132-3
M3 - Article
C2 - 10631335
SN - 0027-5107
VL - 430
SP - 211
EP - 219
JO - Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis
JF - Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis
IS - 2
ER -